Pharma Exclusives Pressreleases
Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
Tuesday, September 23, 2025Longeveron Inca clinical stage biotechnology company developing cellular therapies for lifethreatening rare pediatric and chronic agingrelated conditions today announced that it will participate in the Alliance for Regenerative Medicines Cell Gene M...
Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder
Monday, September 08, 2025Cybin Inc a clinicalstage breakthrough neuropsychiatry company committed to advancing mental healthcare by developing new and innovative nextgeneration treatment options today announced completion of enrollment
Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers
Wednesday, September 03, 2025Allergan Aesthetics an AbbVie company has launched the Naturally You with Injectable Hyaluronic Acid Fillers campaign aimed to providing clear factual education about HA injectable fillers
BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative
Tuesday, September 02, 2025In recognition of Peripheral Artery Disease PAD Awareness Month BD Becton Dickinson and Company NYSE BDX is shining a spotlight on a serious yet often overlooked circulatory disorder that restricts
Merck’s Investigational Oral PCSK9 Inhibitor Enlicitide Decanoate Met All Primary and Key Secondary Endpoints in Adults with Hypercholesterolemia in Pivotal CORALreef Lipids Study
Tuesday, September 02, 2025Merckknown as MSD outside of the United States and Canada today announced positive topline results from the Phase CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate an investigational
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
Friday, August 29, 2025Teva Pharmaceuticals Inc a US affiliate of Teva Pharmaceutical Industries Ltd NYSE and TASE TEVA announced today the FDA approval and US launch of a generic version of Saxenda liraglutide injection
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
Thursday, August 28, 2025Moderna Inctoday announced that the US Food and Drug Administration FDA has approved the supplemental Biologics License Applications sBLA for the formulas for Spikevax and mNEXSPIKE
AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
Monday, August 25, 2025AbbVieand Gilgamesh Pharmaceuticals Inc Gilgamesh today announced a definitive agreement under which AbbVie will acquire Gilgameshs lead investigational candidate currently in clinical development
Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
Friday, August 22, 2025Kite a Gilead Company today announced that it has entered into a definitive agreement to acquire Interius BioTherapeutics a privately held biotechnology company developing in vivo CAR therapeutics for million
Thermo Fisher Scientific Opens Manufacturing Center of Excellence Site in North Carolina
Friday, August 22, 2025Thermo Fisher Scientific Inc the world leader in serving science today announced the grand opening of its innovative manufacturing center of excellence facility in Mebane NC The new squarefoot carbon neutral site
